Patents by Inventor Kimberly Hamad
Kimberly Hamad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230168248Abstract: The present disclosure relates to methods, devices, assays and systems for rapid detection of food-borne pathogens, including Vibrios.Type: ApplicationFiled: April 30, 2021Publication date: June 1, 2023Inventors: Michael SHIARIS, Tiffany GOSINE, Yoichi MURAKAMI, Scott SUNDBERG, Takeshi IMAMURA, Cristina RODRIGUEZ-QUIJADA, Michael TLUSTY, Kimberly HAMAD-SCHIFFERLI
-
Patent number: 11320433Abstract: The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that may contain one or more of such dengue virus serotypes. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample and will not cross react with other serotypes that may be present in the sample. Multiple matched pairs may be used to detect one or more dengue virus serotypes that may be present in a sample. Such matched pair antibodies, facilitate the development of confirmatory in vitro diagnostic tests such as sandwich immunoassays, that detect and distinguish the presence of one or more dengue virus serotypes in a biological sample, preferably a sample derived from human subject.Type: GrantFiled: December 9, 2019Date of Patent: May 3, 2022Assignees: Massachusetts Institute of Technology, The United States of America as Represented by the Secretary of the Department of Health and Human ServicesInventors: Irene Bosch, Kimberly Hamad-Schifferli, Jose Gomez-Marquez, Helena dePuig Guixe, Lee Gehrke
-
Publication number: 20200363415Abstract: The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that may contain one or more of such dengue virus serotypes. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample and will not cross react with other serotypes that may be present in the sample. Multiple matched pairs may be used to detect one or more dengue virus serotypes that may be present in a sample. Such matched pair antibodies, facilitate the development of confirmatory in vitro diagnostic tests such as sandwich immunoassays, that detect and distinguish the presence of one or more dengue virus serotypes in a biological sample, preferably a sample derived from human subject.Type: ApplicationFiled: December 9, 2019Publication date: November 19, 2020Inventors: Irene Bosch, Kimberly Hamad-Schifferli, Jose Gomez-Marquez, Helena dePuig Guixe, Lee Gehrke
-
Patent number: 10551381Abstract: The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that may contain one or more of such dengue virus serotypes. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample and will not cross react with other serotypes that may be present in the sample. Multiple matched pairs may be used to detect one or more dengue virus serotypes that may be present in a sample. Such matched pair antibodies, facilitate the development of confirmatory in vitro diagnostic tests such as sandwich immunoassays, that detect and distinguish the presence of one or more dengue virus serotypes in a biological sample, preferably a sample derived from human subject.Type: GrantFiled: February 10, 2017Date of Patent: February 4, 2020Assignees: Massachusetts Institute of Technology, The United States of America as Represented by the Secretary of the Department of Health and Human ServicesInventors: Irene Bosch, Kimberly Hamad-Schifferli, Jose Gomez-Marquez, Helena de Puig, Lee Gehrke
-
Publication number: 20180372755Abstract: The present invention provides a multiplexed immunoassay which leverages stockpiled antibodies to detect whether a patient has been infected with an emerging disease which does not have specific antibodies raised against it (FIG. 1). The assay is preferably designed as a paper-based assay, which allows diagnosis at point of care (POC) and readout by eye or mobile phone. Paper-based rapid diagnostic tests (RDTs) are convenient, robust, and can be read out within minutes. The immunoassay of the invention combines the strategic use of nanoparticles of assorted colors with readily available stockpiled antibodies to one or more biomarkers of disease, particularly viral diseases.Type: ApplicationFiled: June 22, 2018Publication date: December 27, 2018Inventors: Lee Gehrke, Helena de Puig Guixe, Irene Bosch, Jose Gomez-Marquez, Kimberly Hamad-Schifferli
-
Publication number: 20170233460Abstract: The present invention provides matched antibody pairs for the specific detection of one or more of the four dengue virus serotypes in a biological sample that may contain one or more of such dengue virus serotypes. Each matched antibody pair is capable of detecting not more than one serotype of dengue virus NS1 protein that may be present in the sample and will not cross react with other serotypes that may be present in the sample. Multiple matched pairs may be used to detect one or more dengue virus serotypes that may be present in a sample. Such matched pair antibodies, facilitate the development of confirmatory in vitro diagnostic tests such as sandwich immunoassays, that detect and distinguish the presence of one or more dengue virus serotypes in a biological sample, preferably a sample derived from human subject.Type: ApplicationFiled: February 10, 2017Publication date: August 17, 2017Inventors: Irene Bosch, Kimberly Hamad-Schifferli, Jose Gomez-Marquez, Helena de Puig, Lee Gehrke
-
Publication number: 20170234866Abstract: The present invention provides a lateral flow multiplex assay strip, and lateral flow assay systems and kits comprising the assay strips of the invention and methods of using the assay strip and systems and kits to detect the levels of two or more target analytes that may be present in a liquid sample, wherein the two more target analytes are detectable at a single test area of the assay.Type: ApplicationFiled: February 11, 2016Publication date: August 17, 2017Inventors: Kimberly Hamad-Schifferli, Irene Bosch, Chun-Wan Yen, Helena de Puig, Justina O. Tam, Lee Gehrke
-
Patent number: 9545383Abstract: The disclosure is directed to enabling reversible, on-demand remote control of blood clotting and clot dissolution. In one embodiment, a laser at one wavelength triggers release of a DNA thrombin inhibitor from one nanorod, which acts as an anticoagulant to stop blood clotting. Another wavelength triggers release of a specific antidote, which reverses the effect of the thrombin inhibitor, restoring blood clotting.Type: GrantFiled: March 31, 2015Date of Patent: January 17, 2017Assignee: Massachusetts Institute of TechnologyInventors: Kimberly Hamad-Schifferli, Salmaan H. Baxamusa, Helena de Puig Guixe
-
Publication number: 20150272899Abstract: The disclosure is directed to enabling reversible, on-demand remote control of blood clotting and clot dissolution. In one embodiment, a laser at one wavelength triggers release of a DNA thrombin inhibitor from one nanorod, which acts as an anticoagulant to stop blood clotting. Another wavelength triggers release of a specific antidote, which reverses the effect of the thrombin inhibitor, restoring blood clotting.Type: ApplicationFiled: March 31, 2015Publication date: October 1, 2015Applicant: Massachusetts Institute of TechnologyInventors: Kimberly Hamad-Schifferli, Salmaan H. Baxamusa, Helena de Puig Guixe
-
Publication number: 20070164250Abstract: This invention provides magnetic nanoparticles, which when placed in a magnetic field are selectively heated at a certain frequency of the magnetic field, as a function of their size, composition, or both. The invention also provides for use of such nanoparticles, in applications including, inter alia, selective nanoparticle heating and applications thereof, hyperthermia induction in cells or tissue, remote alteration of protein structure and/or drug delivery.Type: ApplicationFiled: October 27, 2006Publication date: July 19, 2007Inventors: Kimberly Hamad-Schifferli, Andy Wijaya
-
Patent number: 6953656Abstract: Methods and compositions for rendering proteins directly responsive to an external signal utilizing modulators that themselves respond to the external signal and are associated with the proteins. In response to the external signal, the modulator alters physical properties of the specific protein molecule(s) with which it is associated, thereby altering the structural and functional properties thereof. The modulator may, for example, transfer applied energy to a protein, or to a portion of the protein, thereby changing the protein structure and function.Type: GrantFiled: July 13, 2001Date of Patent: October 11, 2005Assignee: Massachusetts Institute of TechnologyInventors: Joseph M. Jacobson, John J. Schwartz, Kimberly Hamad, Shuguang Zhang
-
Patent number: 6953659Abstract: Methods and compositions for rendering nucleic acids directly responsive to an external signal utilizing modulators that themselves respond to the external signal and are associated with the nucleic acid. In response to the external signal, the modulator alters physical properties of the specific nucleic acid molecule(s) with which it is associated, thereby altering the structural and functional properties thereof. The modulator may, for example, transfer applied energy to a nucleic acid, or to a portion of the nucleic acid, thereby changing the nucleic acid structure.Type: GrantFiled: July 13, 2001Date of Patent: October 11, 2005Assignee: Massachusetts Institute of TechnologyInventors: Joseph M. Jacobson, John J. Schwartz, Kimberly Hamad, Shuguang Zhang
-
Publication number: 20020119572Abstract: Methods and compositions for rendering proteins directly responsive to an external signal utilizing modulators that themselves respond to the external signal and are associated with the proteins. In response to the external signal, the modulator alters physical properties of the specific protein molecule(s) with which it is associated, thereby altering the structural and functional properties thereof. The modulator may, for example, transfer applied energy to a protein, or to a portion of the protein, thereby changing the protein structure and function.Type: ApplicationFiled: July 13, 2001Publication date: August 29, 2002Inventors: Joseph M. Jacobson, John J. Schwartz, Kimberly Hamad, Shuguang Zhang
-
Publication number: 20020061588Abstract: Methods and compositions for rendering nucleic acids directly responsive to an external signal utilizing modulators that themselves respond to the external signal and are associated with the nucleic acid. In response to the external signal, the modulator alters physical properties of the specific nucleic acid molecule(s) with which it is associated, thereby altering the structural and functional properties thereof. The modulator may, for example, transfer applied energy to a nucleic acid, or to a portion of the nucleic acid, thereby changing the nucleic acid structure.Type: ApplicationFiled: July 13, 2001Publication date: May 23, 2002Inventors: Joseph M. Jacobson, John J. Schwartz, Kimberly Hamad, Shuguang Zhang